VisEn Medical Launches FMT™ 2500 – Next-Generation Fluorescence Imaging System
New Instrument Generates Real-Time In Vivo Data via Quantitative Tomography
VisEn Medical Raises $5.0 Million in Expanded Series B Financing
Woburn, MA, April 18, 2008 -- VisEn Medical, Inc., a leader in fluorescence in vivo imaging, today announced the expansion of its Series B financing. Merck Capital Ventures and Flagship Ventures co-led this $5.0 million expansion of the Series B round, which initially raised $7 million in November 2007, bringing the total Series B financing amount to $12.0 million. VisEn will use the additional financing to further advance its proprietary fluorescence in vivo imaging product pipelines, and to expand its commercial applications and customer support of its marketed products worldwide.
Resolvyx Pharmaceuticals Strengthens Its Board of Directors with Industry Leaders
BEDFORD, Mass.--(BUSINESS WIRE)--Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced the appointment of Timothy J. Barberich and George M. Milne, Jr., Ph.D, to Resolvyx's Board of Directors. Resolvyx is focused on developing drugs based on resolvins, a recently discovered family of naturally-occurring, small molecule lipid mediators that actively resolve inflammation and can be targeted to treat a wide range of diseases, including asthma, cardiovascular disease and multiple eye diseases.
Resolvyx Pharmaceuticals Raises $25 Million in Series B Financing
Company Advancing Resolvin Therapeutics to Initiate Human Clinical Trials in 2008
Black Duck Software Acquires Software Code Search Leader Koders
WALTHAM, Mass. - (Business Wire) Black Duck Software, the leading global provider of products and services for accelerating software development through the managed use of open source software, today announced it has acquired the assets of Koders as well as the company’s popular on-line search engine for open source software and other web-downloadable code. Black Duck will improve the free online search site and incorporate Koders’ search capability into its highly successful open source product portfolio.
Helicos BioSciences Reports Q1 2008 Financial Results
CAMBRIDGE, Mass., Apr 29, 2008 (BUSINESS WIRE) -- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today its financial results for the quarter ended March 31, 2008.
CoNCERT Pharmaceuticals Raises $37 Million in Series C Financing
Broad Syndicate of New and Existing Investors
Genstruct and Sirtris Pharmaceuticals Win Bio-IT World’s Best Practices Award
Causal Network Modeling Provides Powerful Approach to Modeling Complex Biological Systems for Type 2 Diabetes
GM and Mascoma Enter into Biofuels Relationship
Automaker to Help Speed One-Step Cellulose-to-Fuels Process to Market
WASHINGTON, May 1 – General Motors Corp. and Mascoma Corp. today announced a strategic relationship to develop cellulosic ethanol focused on Mascoma’s single-step biochemical conversion of non-grain biomass into low-carbon alternative fuels to help address increasing energy demand.
Mascoma Corporation Raises $61 Million in Third Round of Funding
Marathon Oil Corporation Leads Round